
Whitepapers


This paper includes a brief introduction to light scattering instruments and techniques, and how they are coupled with fractionation techniques. For several classes of vaccines – including subunit vaccines, mRNA-LNPs, polysaccharide conjugates, and plain old viruses – case studies demonstrate the utility and breadth of analyses using the light scattering toolkit. These include measuring size distributions, characterizing protein-protein binding, and quantifying glycan content in glycoproteins or nucleic acid cargo in nanocarriers. Multiple ways to detect aggregation and other measures of stability are also described.





4D-LC/MS allows characterization of mAbs by cation-exchange chromatography followed by online desalting, denaturation, reduction, tryptic digestion and peptide mapping.


Digital transformation centered on LIMS turns data into the knowledge that improves outcomes. What can you learn from three real-world transformations? Read our white paper.

The proportional–integral–derivative (PID) control mechanism is used for a variety of processes, including dissolved oxygen (DO) control. This protocol introduces a method developed to optimize the PI values on Eppendorf bioprocess controllers.

Combining high performance protein A capturing and a single polishing step on a salt-tolerant anion exchange resin, downstream costs were reduced by 45% in this Tosoh 2-step process for mAb purification.

This whitepaper will look at how integrating the SEC-MALS method at an earlier stage in the development process will accelerate speed-to-clinic without compromising patient safety.

Get more out of your sample prep. Prevent sample failures in bioanalytical workflows and search application notes by your compounds of interest, application area, SOLA chemistry phases or SOLA formats.

Efficient virus recovery and impurity removal are challenges for purification of viruses such as H1N1. In a single purification step, Nuvia HP-Q AEX Resin resulted in excellent recovery and impurity removal.

Traditional sequential chromatography usually requires user manipulation which may hinder reproducibility in protein purification runs. Multidimensional chromatography improves the process without sacrificing efficacy. This study compares both purification workflows demonstrating equivalent purity.

Roche Pharma Research and Early Development lab automation specialist, Pawel Linke, discusses their approach to doubling the number of projects in process development without significantly increasing headcount.

This application note collection will help ensure you have the right tools to succeed in the biopharmaceutical environment, from research and process development to quality control.

The traditional packaging for frozen BDS applications has significant weaknesses at lower temperatures. This paper discusses new materials and freeze-thaw systems to meet these challenges.


An industrial biotechnology company in Denmark required more rigorous control measures to ensure a high level of bio-decontamination in its facility. An automated hydrogen peroxide vapor service from Bioquell was selected.


Glycosylation homogeneity and pattern can be increase with cell line engineering and bioprocess optimization. But, these can be time-consuming and might compromise yield. In vitro glycoengineering can solve these problems and is independent from the cell line and the bioprocess used.

Protect the integrity of your data with technologies that meet regulatory requirements for secure, accurate data capture and record-keeping.

In 2019, G-CON provided the cleanroom solution for GenCure’s new multi-product cell therapy facility. The new facility expands GenCure’s manufacturing capabilities, providing state-of-the-art manufacturing services to therapeutic developers.


High-density cell banking accelerates the upstream process by providing concentrated cells to jumpstart a production run. This intensification eliminates many laborious and risky steps used in most labs



Cerba Research initiated custom kit building and distribution for an infectious disease study, during the COVID-19 pandemic, in 10 days. A typical timeline is 8 weeks.

Bridging Anti-CHO HCP Antibodies from Two 3rd Generation Cygnus CHO HCP ELISA Kits by AAE-MS
